3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Thyroid Cancer, Papillary
1
Sarcoma
1
Salivary Gland Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Melanoma
1
Lymphoma, Large-Cell, Anaplastic
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Specimen Handling
3
fludarabine
2
aldesleukin
2
Sunitinib
2
Fluorouracil
2
Cyclophosphamide
2
Bevacizumab
2
trastuzumab deruxtecan
1
sodium propionate
1
semaglutide
1
repotrectinib
1
patritumab deruxtecan
1
isosorbide-5-mononitrate
1
fludarabine phosphate
1
dehydroftorafur
1
Tomography, X-Ray Computed
1
Radiosurgery
1
Positron-Emission Tomography
1
Photography
1
Pemetrexed
1
Pafolacianine
1
Memantine
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Isosorbide
1
Irinotecan
1
Interleukin-2
1
IDRX-42
1
High-Intensity Interval Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
entrectinib
×
30 days
×
Clear all
No trials found.